People: Eli Lilly and Co (LLY.N)
24 Feb 2017
Dr. John C. Lechleiter, Ph.D. is no longer Chairman of the Board of Eli Lilly And Co., effective May 31, 2017. He resigned as President, Chief Executive Officer effective December 31, 2016. A Ph.D. chemist by training, Dr. Lechleiter has over 37 years of experience with the company in a variety of roles of increasing responsibility in research and development, pharmaceutical operations, and corporate administration. As a result, he has a sound understanding of pharmaceutical research and development, sales and marketing, and manufacturing.
|Total Annual Compensation, USD||5,122,500|
|Restricted Stock Awards, USD||11,350,000|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||90,000|
|Fiscal Year Total, USD||16,562,500|